标题
Medical Management and Prevention of Motor Complications in Parkinson’s Disease
作者
关键词
-
出版物
Neurotherapeutics
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-08-06
DOI
10.1007/s13311-020-00889-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Randomized Delayed-Start Trial of Levodopa in Parkinson’s Disease
- (2019) Constant V.M. Verschuur et al. NEW ENGLAND JOURNAL OF MEDICINE
- EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease
- (2019) Haidar S. Dafsari et al. MOVEMENT DISORDERS
- Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial
- (2019) Peter A LeWitt et al. LANCET NEUROLOGY
- Should there be less emphasis on levodopa‐induced dyskinesia in Parkinson's disease?
- (2019) K. Ray Chaudhuri et al. MOVEMENT DISORDERS
- Orally inhaled levodopa (CVT-301) for early morning OFF periods in Parkinson's disease
- (2019) Robert A. Hauser et al. PARKINSONISM & RELATED DISORDERS
- Prevalence of Dyskinesia and OFF by 30-Minute Intervals Through the Day and Assessment of Daily Episodes of Dyskinesia and OFF: Novel Analyses of Diary Data from Gocovri Pivotal Trials
- (2019) Robert A. Hauser et al. Journal of Parkinsons Disease
- Current Practices for Outpatient Initiation of Levodopa-Carbidopa Intestinal Gel for Management of Advanced Parkinson’s Disease in the United States
- (2019) Fahd Amjad et al. ADVANCES IN THERAPY
- Pharmacodynamics, Efficacy, and Safety of IPX203 in Parkinson Disease Patients With Motor Fluctuations
- (2019) Nishit B. Modi et al. CLINICAL NEUROPHARMACOLOGY
- Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets
- (2019) Tina deVries et al. CNS DRUGS
- Predictors of motor complications in early Parkinson's disease: A prospective cohort study
- (2019) Mark J. Kelly et al. MOVEMENT DISORDERS
- Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations
- (2019) Federico Carbone et al. CNS DRUGS
- Safety Profile of Opicapone in the Management of Parkinson’s Disease
- (2019) Andrew Lees et al. Journal of Parkinsons Disease
- The Patient's Perspective on Shared Decision-Making in Advanced Parkinson's Disease: A Cross-Sectional Survey Study
- (2019) Frouke A. P. Nijhuis et al. Frontiers in Neurology
- Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study
- (2019) C Warren Olanow et al. LANCET NEUROLOGY
- Dyskinesia matters
- (2019) M. Angela Cenci et al. MOVEMENT DISORDERS
- Inhaled levodopa in Parkinson's disease patients with OFF periods: A randomized 12-month pulmonary safety study
- (2019) Donald G. Grosset et al. PARKINSONISM & RELATED DISORDERS
- Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease
- (2018) Lawrence W. Elmer et al. CNS DRUGS
- Pulmonary Safety and Tolerability of Inhaled Levodopa (CVT-301) Administered to Patients with Parkinson's Disease
- (2018) Peter A. LeWitt et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Apomorphine and levodopa infusion for motor fluctuations and dyskinesia in advanced Parkinson disease
- (2018) Angelo Antonini et al. JOURNAL OF NEURAL TRANSMISSION
- International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
- (2018) Susan H. Fox et al. MOVEMENT DISORDERS
- Comparison of dystonia between Parkinson's disease and atypical parkinsonism: The clinical usefulness of dystonia distribution and characteristics in the differential diagnosis of parkinsonism
- (2018) Won Tae Yoon Neurologia i Neurochirurgia Polska
- Effectiveness of opicapone and switching from entacapone in fluctuating Parkinson disease
- (2018) Joaquim J. Ferreira et al. NEUROLOGY
- The spectrum of “off” in Parkinson's disease: What have we learned over 40 years?
- (2018) Kelvin L. Chou et al. PARKINSONISM & RELATED DISORDERS
- Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
- (2018) Regina Katzenschlager et al. LANCET NEUROLOGY
- Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features
- (2018) K. Ray Chaudhuri et al. MOVEMENT DISORDERS
- Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine
- (2018) Margherita Fabbri et al. MOVEMENT DISORDERS
- Safety and effectiveness of istradefylline in patients with Parkinson’s disease: interim analysis of a post-marketing surveillance study in Japan
- (2018) Makio Takahashi et al. EXPERT OPINION ON PHARMACOTHERAPY
- Continuous Drug Delivery Aiming Continuous Dopaminergic Stimulation in Parkinson’s Disease
- (2018) Daniel J. van Wamelen et al. Journal of Parkinsons Disease
- Long-term adherence to apomorphine infusion in patients with Parkinson disease: a 10-year observational study
- (2017) Thomas E. Kimber et al. INTERNAL MEDICINE JOURNAL
- Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs
- (2017) Yoshikuni Mizuno et al. JOURNAL OF NEURAL TRANSMISSION
- Continuous subcutaneous apomorphine infusion in advanced Parkinson’s disease: 10-year experience with 230 patients
- (2017) Ángel Sesar et al. JOURNAL OF NEUROLOGY
- Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3)
- (2017) Wolfgang Oertel et al. MOVEMENT DISORDERS
- Motor complications in Parkinson's disease: Striatal molecular and electrophysiological mechanisms of dyskinesias
- (2017) Barbara Picconi et al. MOVEMENT DISORDERS
- Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations
- (2017) Anthony H. V. Schapira et al. JAMA Neurology
- Opicapone as Adjunct to Levodopa Therapy in Patients With Parkinson Disease and Motor Fluctuations
- (2017) Andrew J. Lees et al. JAMA Neurology
- ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study)
- (2017) Rajesh Pahwa et al. JAMA Neurology
- Clinical Pharmacokinetics of IPX066
- (2016) Hsuan-Ming Yao et al. CLINICAL NEUROPHARMACOLOGY
- Clinical Pharmacokinetics and Pharmacodynamics of Safinamide
- (2016) Thomas Müller et al. CLINICAL PHARMACOKINETICS
- Novel Levodopa Formulations for Parkinson’s Disease
- (2016) Maria Eliza Freitas et al. CNS DRUGS
- Quality of life in Parkinson’s disease improved by apomorphine pump: the OPTIPUMP cohort study
- (2016) Sophie Drapier et al. JOURNAL OF NEUROLOGY
- Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial
- (2016) Joaquim J Ferreira et al. LANCET NEUROLOGY
- Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients
- (2016) Angelo Antonini et al. MOVEMENT DISORDERS
- A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease
- (2016) Peter A. LeWitt et al. MOVEMENT DISORDERS
- Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's disease
- (2016) Robert A. Hauser et al. MOVEMENT DISORDERS
- Levodopa therapy for Parkinson disease: Table
- (2016) Peter A. LeWitt et al. NEUROLOGY
- Parkinson's disease, visual hallucinations and apomorphine: A review of the available evidence
- (2016) Robbert W.K. Borgemeester et al. PARKINSONISM & RELATED DISORDERS
- Motor and non-motor outcomes of continuous apomorphine infusion in 125 Parkinson's disease patients
- (2016) Robbert W.K. Borgemeester et al. PARKINSONISM & RELATED DISORDERS
- Preclinical and clinical assessment of inhaled levodopa for OFF episodes in Parkinsons disease
- (2016) M. M. Lipp et al. Science Translational Medicine
- Comparison of the pharmacokinetics of an oral extended-release capsule formulation of carbidopa-levodopa (IPX066) with immediate-release carbidopa-levodopa (Sinemet®), sustained-release carbidopa-levodopa (Sinemet® CR), and carbidopa-levodopa-entacapone (
- (2015) Ann Hsu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Zonisamide improves wearing-off in Parkinson's disease: A randomized, double-blind study
- (2015) Miho Murata et al. MOVEMENT DISORDERS
- MDS clinical diagnostic criteria for Parkinson's disease
- (2015) Ronald B. Postuma et al. MOVEMENT DISORDERS
- The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa
- (2014) R. Cilia et al. BRAIN
- Safety and Efficacy of Tolcapone in the Long-term Use in Parkinson Disease
- (2014) Karla Eggert et al. CLINICAL NEUROPHARMACOLOGY
- Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations
- (2014) José-Francisco Rocha et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial
- (2014) PD MED Collaborative Group LANCET
- Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease
- (2014) Rupam Borgohain et al. MOVEMENT DISORDERS
- Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: Final 12-month, open-label results
- (2014) Hubert H. Fernandez et al. MOVEMENT DISORDERS
- Clinical spectrum of levodopa-induced complications
- (2014) Camila Catherine Aquino et al. MOVEMENT DISORDERS
- EuroInf: AMulticenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease
- (2014) Pablo Martinez-Martin et al. MOVEMENT DISORDERS
- Comparison of IPX066 with carbidopa–levodopa plus entacapone in advanced PD patients
- (2014) Fabrizio Stocchi et al. PARKINSONISM & RELATED DISORDERS
- Randomized, placebo-controlled trial of trimethobenzamide to control nausea and vomiting during initiation and continued treatment with subcutaneous apomorphine injection
- (2014) Robert A. Hauser et al. PARKINSONISM & RELATED DISORDERS
- Non-dopaminergic Treatments for Motor Control in Parkinson’s Disease
- (2013) Susan H. Fox DRUGS
- Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience
- (2013) M. Zibetti et al. EUROPEAN JOURNAL OF NEUROLOGY
- Reduction in Parkinson’s Disease Therapy Improved Punding But Not Feeling of Presence
- (2013) Camila Catherine Aquino et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial
- (2013) Robert A Hauser et al. LANCET NEUROLOGY
- Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
- (2013) C Warren Olanow et al. LANCET NEUROLOGY
- Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations
- (2013) Rupam Borgohain et al. MOVEMENT DISORDERS
- Adenosine A2Areceptor antagonist istradefylline reduces daily OFF time in Parkinson's disease
- (2013) Yoshikuni Mizuno et al. MOVEMENT DISORDERS
- Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease
- (2013) C. Warren Olanow et al. MOVEMENT DISORDERS
- Withdrawing amantadine in dyskinetic patients with Parkinson disease: The AMANDYSK trial
- (2013) F. Ory-Magne et al. NEUROLOGY
- Early DEtection of wEaring off in Parkinson disease: The DEEP study
- (2013) F. Stocchi et al. PARKINSONISM & RELATED DISORDERS
- Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson’s disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER
- (2012) Peter A. LeWitt et al. JOURNAL OF NEURAL TRANSMISSION
- Long-term duodenal levodopa infusion in Parkinson’s disease: a 3-year motor and cognitive follow-up study
- (2012) Maurizio Zibetti et al. JOURNAL OF NEUROLOGY
- Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease
- (2011) Robert A. Hauser et al. MOVEMENT DISORDERS
- Extended-release pramipexole in advanced Parkinson disease: A randomized controlled trial
- (2011) A. H. V. Schapira et al. NEUROLOGY
- Apomorphine infusion in advanced Parkinson’s patients with subthalamic stimulation contraindications
- (2011) Sophie Drapier et al. PARKINSONISM & RELATED DISORDERS
- Amantadine for Dyskinesias in Parkinson's Disease: A Randomized Controlled Trial
- (2011) Hideyuki Sawada et al. PLoS One
- Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE-PD study
- (2010) Fabrizio Stocchi et al. ANNALS OF NEUROLOGY
- Management of punding in Parkinson’s disease: an open-label prospective study
- (2010) A. Fasano et al. JOURNAL OF NEUROLOGY
- Long-term antidyskinetic efficacy of amantadine in Parkinson's disease
- (2010) Elisabeth Wolf et al. MOVEMENT DISORDERS
- Levodopa-induced belly dancer's dyskinesias in Parkinson's disease: Report of one case
- (2010) Miryam Carecchio et al. MOVEMENT DISORDERS
- Clinical efficacy of istradefylline (KW-6002) in Parkinson's disease: A randomized, controlled study
- (2010) Yoshikuni Mizuno et al. MOVEMENT DISORDERS
- Long-term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease
- (2009) ARCHIVES OF NEUROLOGY
- Continuous Jejunal Levodopa Infusion in Patients With Advanced Parkinson Disease
- (2009) Karla Eggert et al. CLINICAL NEUROPHARMACOLOGY
- Therapy adherence issues in Parkinson's disease
- (2009) Donald Grosset JOURNAL OF THE NEUROLOGICAL SCIENCES
- Multiple system atrophy: an update
- (2009) Nadia Stefanova et al. LANCET NEUROLOGY
- A reassessment of risks and benefits of dopamine agonists in Parkinson's disease
- (2009) Angelo Antonini et al. LANCET NEUROLOGY
- Adherence to antiparkinson medication in a multicenter European study
- (2009) Donald Grosset et al. MOVEMENT DISORDERS
- Adenosine A2Areceptor antagonist istradefylline (KW-6002) reduces “off” time in Parkinson's disease: A double-blind, randomized, multicenter clinical trial (6002-US-005)
- (2008) Peter A. LeWitt et al. ANNALS OF NEUROLOGY
- Evidence-Based Efficacy Comparison of Tolcapone and Entacapone as Adjunctive Therapy in Parkinson's Disease
- (2008) Andrew J. Lees CNS Neuroscience & Therapeutics
- Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations
- (2008) Robert A. Hauser et al. MOVEMENT DISORDERS
- The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
- (2008) Mariese A. Hely et al. MOVEMENT DISORDERS
- Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study
- (2008) Pedro J. García Ruiz et al. MOVEMENT DISORDERS
- Amantadine may reverse punding in Parkinson's disease-Observation in a patient
- (2007) Kenichi Kashihara et al. MOVEMENT DISORDERS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started